Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States
- PMID: 35143100
- PMCID: PMC9111251
- DOI: 10.1111/ajt.16995
Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States
Abstract
An electronic survey canvassing current policies of transplant centers regarding a COVID-19 vaccine mandate for transplant candidates and living donors was distributed to clinicians at US solid organ transplant centers performing transplants from October 14, 2021-November 15, 2021. Responses were received from staff at 141 unique transplant centers. These respondents represented 56.4% of US transplant centers, and responding centers performed 78.5% of kidney transplants and 82.4% of liver transplants in the year prior to survey administration. Only 35.7% of centers reported implementing a vaccine mandate, while 60.7% reported that vaccination was not required. A minority (42%) of responding centers with a vaccine mandate for transplant candidates also mandated vaccination for living organ donors. Centers with a vaccine mandate most frequently cited clinical evidence supporting the efficacy of pre-transplant vaccination (82%) and stewardship obligations to ensure organs were transplanted into the lowest risk patients (64%). Centers without a vaccine mandate cited a variety of reasons including administrative, equity, and legal considerations for their decision. Transplant centers in the United States exhibit significant heterogeneity in COVID-19 vaccination mandate policies for transplant candidates. While all centers encourage vaccination, most centers have not mandated COVID-19 vaccination for candidates and living donors, citing administrative opposition, legal prohibitions, and concern about equity in access to transplants.
Keywords: SARS-CoV-2/COVID-19; ethics; ethics and public policy; infection and infectious agents - viral; infectious disease; patient safety; solid organ transplantation; vaccine.
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures
References
-
- Belli LS, Duvoux C, Cortesi PA, et al. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. Gut. 2021;70(10):1914–1924. - PubMed
-
- American Society of Transplantation (AST). Statement about Vaccine Efficacy in Organ Transplant Recipients. https://www.myast.org/sites/default/files/ast%20ishlt%20guidance%20vacci.... Accessed November 18, 2021
-
- American Society of Transplant Surgeons (ASTS). ASTS Position on COVID-19 Vaccine and Transplant Patients. https://asts.org/news-and-publications/asts-news/2021/08/25/asts-positio.... Accessed November 18, 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
